NO20015636L - Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives - Google Patents

Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Info

Publication number
NO20015636L
NO20015636L NO20015636A NO20015636A NO20015636L NO 20015636 L NO20015636 L NO 20015636L NO 20015636 A NO20015636 A NO 20015636A NO 20015636 A NO20015636 A NO 20015636A NO 20015636 L NO20015636 L NO 20015636L
Authority
NO
Norway
Prior art keywords
cinnamoylaminoalkyl
benzenesulfonamide derivatives
substituted benzenesulfonamide
substituted
derivatives
Prior art date
Application number
NO20015636A
Other languages
Norwegian (no)
Other versions
NO20015636D0 (en
NO321558B1 (en
Inventor
Holger Heitsch
Heinrich Christian Englert
Klaus Wirth
Heinz Goegelein
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20015636D0 publication Critical patent/NO20015636D0/en
Publication of NO20015636L publication Critical patent/NO20015636L/en
Publication of NO321558B1 publication Critical patent/NO321558B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/53—X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52—Y being a hetero atom
    • C07C311/54—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58—Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20015636A 1999-05-20 2001-11-19 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives NO321558B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19923086A DE19923086A1 (en) 1999-05-20 1999-05-20 New cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives, are ATP-sensitive potassium channel inhibitors and vagal nervous system stimulants useful for treating cardiovascular disorders
PCT/EP2000/004091 WO2000071513A1 (en) 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Publications (3)

Publication Number Publication Date
NO20015636D0 NO20015636D0 (en) 2001-11-19
NO20015636L true NO20015636L (en) 2002-01-15
NO321558B1 NO321558B1 (en) 2006-05-29

Family

ID=7908577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015636A NO321558B1 (en) 1999-05-20 2001-11-19 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Country Status (30)

Country Link
US (1) US6350778B1 (en)
EP (1) EP1183236B1 (en)
JP (1) JP4559640B2 (en)
KR (1) KR100968729B1 (en)
CN (1) CN1243730C (en)
AR (1) AR035625A1 (en)
AT (1) ATE252554T1 (en)
AU (1) AU771675B2 (en)
BR (1) BR0010821B1 (en)
CA (1) CA2374226C (en)
CZ (1) CZ302943B6 (en)
DE (2) DE19923086A1 (en)
DK (1) DK1183236T3 (en)
EE (1) EE04611B1 (en)
ES (1) ES2208342T3 (en)
HK (1) HK1047574B (en)
HR (1) HRP20010845B1 (en)
HU (1) HU229041B1 (en)
IL (2) IL146372A0 (en)
ME (1) MEP41508A (en)
MX (1) MXPA01011725A (en)
NO (1) NO321558B1 (en)
PL (1) PL201560B1 (en)
PT (1) PT1183236E (en)
RS (1) RS50172B (en)
RU (1) RU2242462C2 (en)
SK (1) SK287237B6 (en)
TR (1) TR200103312T2 (en)
WO (1) WO2000071513A1 (en)
ZA (1) ZA200109481B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054481A1 (en) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them
DE10054482A1 (en) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their production, their use and pharmaceutical preparations containing them
CN1237185C (en) * 2003-06-04 2006-01-18 中国科学院上海药物研究所 SARS coronavirus 3Cl protease two-dimensional model and medicine preventing SARS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1185180B (en) 1963-10-19 1965-01-14 Hoechst Ag Process for the preparation of benzenesulfonylureas
DE1518874C3 (en) * 1964-10-07 1975-03-13 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzenesulfonylureas and process for their preparation
DE1518816C3 (en) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzenesulfonylureas, processes for their preparation and pharmaceutical preparations containing them
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE1545810A1 (en) * 1965-05-06 1969-12-11 Hoechst Ag Process for the preparation of benzenesulfonylsemicarbazides
DE2413514C3 (en) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzenesulfonyl-N'-methylureas, process for their preparation and their use
ES2098069T3 (en) 1993-02-23 1997-04-16 Hoechst Ag SUBSTITUTED BENZENE SULFONYL-UREAS AND -TIOUREAS, PROCEDURE FOR THEIR PREPARATION AND USE AS PHARMACEUTICAL AGENTS.
DE4341655A1 (en) 1993-12-07 1995-06-08 Hoechst Ag Amino-substituted benzenesulfonylureas and thioureas, processes for their preparation and their use as pharmaceuticals
JPH0826995A (en) * 1994-07-22 1996-01-30 Nisshin Flour Milling Co Ltd Antiarrhythmic agent containing benzimidazole derivative
DE19505397A1 (en) * 1995-02-17 1996-08-22 Hoechst Ag Substituted benzenesulfonylureas and thioureas, processes for their preparation, their use as medicaments or diagnostic agents and medicaments containing them
DE19832009A1 (en) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh New 2,5-disubstituted benzenesulfonyl-ureas or -thioureas, used as ATP-sensitive potassium channel blockers for treating cardiovascular disorders such as arrhythmia or cardiac insufficiency
CZ301165B6 (en) 1998-09-10 2009-11-25 Sanofi - Aventis Deutschland GmbH Use of benzenesulfonyl(thio) ureas for treating and prophylaxis of autonomous nervous system dysfunctions and use of the benzenesulfonyl(thio) ureas in combination with beta-receptor blockers
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors

Also Published As

Publication number Publication date
RU2242462C2 (en) 2004-12-20
PT1183236E (en) 2004-03-31
WO2000071513A1 (en) 2000-11-30
CN1360571A (en) 2002-07-24
EP1183236A1 (en) 2002-03-06
HUP0201906A2 (en) 2002-09-28
EE200100609A (en) 2003-02-17
PL351751A1 (en) 2003-06-16
MXPA01011725A (en) 2002-04-24
TR200103312T2 (en) 2002-04-22
BR0010821B1 (en) 2011-07-12
MEP41508A (en) 2011-02-10
KR20020005046A (en) 2002-01-16
JP2003500388A (en) 2003-01-07
JP4559640B2 (en) 2010-10-13
US6350778B1 (en) 2002-02-26
SK287237B6 (en) 2010-04-07
HUP0201906A3 (en) 2005-04-28
CA2374226C (en) 2010-08-31
DE60006104D1 (en) 2003-11-27
CN1243730C (en) 2006-03-01
NO20015636D0 (en) 2001-11-19
BR0010821A (en) 2002-03-05
IL146372A0 (en) 2002-07-25
AR035625A1 (en) 2004-06-23
EE04611B1 (en) 2006-04-17
RS50172B (en) 2009-05-06
EP1183236B1 (en) 2003-10-22
CZ20014149A3 (en) 2002-03-13
SK16692001A3 (en) 2002-04-04
AU771675B2 (en) 2004-04-01
HU229041B1 (en) 2013-07-29
HRP20010845A9 (en) 2010-06-30
PL201560B1 (en) 2009-04-30
DK1183236T3 (en) 2004-02-23
ES2208342T3 (en) 2004-06-16
ZA200109481B (en) 2002-06-25
NO321558B1 (en) 2006-05-29
AU5393300A (en) 2000-12-12
HK1047574B (en) 2006-08-04
KR100968729B1 (en) 2010-07-08
YU81701A (en) 2004-07-15
DE60006104T2 (en) 2004-08-05
ATE252554T1 (en) 2003-11-15
CA2374226A1 (en) 2000-11-30
IL146372A (en) 2007-05-15
HRP20010845A2 (en) 2003-04-30
HRP20010845B1 (en) 2010-08-31
DE19923086A1 (en) 2000-11-23
HK1047574A1 (en) 2003-02-28
CZ302943B6 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
PT1175408E (en) SULFONAMIDE DERIVATIVES
IS2116B (en) 4-phenyl-pyridine derivatives
NO20021077D0 (en) Amino-triazolopyridin derivatives
DE60009747D1 (en) ADMANTAN DERIVATIVES
DE50010060D1 (en) THIAZOLYLAMID DERIVATIVES
IS6128A (en) 13-Methyl-erythromycin derivatives
DK1187814T3 (en) 5-phenyl-pyrimidine derivatives
ATE338021T1 (en) SUBSTITUTED 2-DIALKYLAMINOALKYLBIPHENYL DERIVATIVES
NO20021803L (en) Isoksazolkarboksamid derivatives
ATE257148T1 (en) PROPARGYLETHER DERIVATIVES
ATE374747T1 (en) MONOFLUORALKYL DERIVATIVES
ATE273272T1 (en) MEVINOLINE DERIVATIVES
DK1187815T3 (en) 4-phenyl-pyrimidine derivatives
ATE293592T1 (en) RESOCINE DERIVATIVES
ATE254598T1 (en) 4-HYDROXYBIPHENYLHYDRAZIDE DERIVATIVES
NO20020212D0 (en) 3-amino-2-benzyl-1-phenylpropane derivatives
NO20022867D0 (en) Syklopentenon derivatives
TR200002831A3 (en) Quinolin-4-Il derivatives I
DK1189886T3 (en) Ethanesulfonyl-piperidine derivatives
DE60001736D1 (en) 1-TRIFLUOROTMETHYL-4-HYDROXY-7-PIPERIDINYL-aminomethylchroman DERIVATIVES
DE59909774D1 (en) 1-CYCLOALKYLPYRAZOLYL-BENZOYL DERIVATIVES
ATE252554T1 (en) CINNAMOYLAMINOALKYL-SUBSTITUTED BENZENESULFONAMIDE DERIVATIVES
DK1345892T3 (en) Acylaminoalkyl-substituted benzenesulfonamide derivatives

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees